Plenary Session - Atrial Fibrillation

Chairs: Marc Samama, France
   Edip Gurol, USA

• Synthesis of global ESC & ERHA guidelines - John Camm, UK​​​
• Who not to anticoagulated - John Camm, UK​​
• Addition of aspirin to OAC in stroke patients -Edip Gurol, USA​
• Addition of aspirin to OAC in stented patients ​- Freek Verheugt, The Netherlands
  

Plenary Session - Atrial Fibrillation: alternatives to OACs

​               Chairs: Marc Fisher, USA
                           Freek Verheugt, The Netherlands

• Preventing and managing intracranial hemorrhage while on antithromboltics (risk assessment, antidote, management) - Thorsten Steiner, Germany​
• Is left atrial appendage closure an alternative to anticoagulation? - Thorsten Lewalter, Germany
• Does ablation prevent stroke - Gerhard Hindricks, Germany​

Plenary Session - Atrial Fibrillation

Chairs: Rafael Rosso, Israel
                      Ovidiu Bajenaru, Romania

• Overview of new antidotes - Marc Samama, France
• Long-term cardiac monitoring & cardiac work-up in stroke - Marc Fisher, USA
• Should we anticoagulate all transient AF after stroke/TIA? - Laurent Fauchier, France

Plenary Session - When heart hits the brain

Chairs: Louis Caplan, USA 
TBA

• Stroke post TAVI - Rafael Rosso, Israel
• Stroke post CABG - Dan Longrois, France 
• Stroke post PCI - Andrej Budaj, Poland
• Stroke post Ablation - Rafael Rosso, Israel

Plenary Session – Heart & Brain and drug or drug-drug interaction

Chairs: Matthias Endres, Germany
Marc Fisher, USA 

• Paracetamol/ibuprofen, MI and brain infarction provocative overview - Jaime Gonzales, France
• Dual antiplatelet therapy in MI and brain infarction - Gregory Ducrocq, France
• Microbleeds and use of antithrombitc agents: Is the ICH risk increased? - Edip Gurol, USA

Plenary Session - New players to tackle dyslipidemia in heart & brain diseases

Chairs: Gregory Ducrocq, France
  David Tanne, Israel

• PCSK9-, CETP-, PPARs+ overview - Gabriel Steg, France​
• Other new approaches to dyslipidemia –  Michel Farnier, France​
• LDL target vs percent reduction in stroke prevention? - Pierre Amarenco, France

Plenary Session - Stroke for the "dummies" 1

Chairs: László Csiba, Hungary
              Michael Brainin, Austria

• Carotid artery stenosis and stroke/TIA - Lou Caplan, USA​
• PFO management - Heinrich Mattle, Switzerland
• Troponin elevation in stroke/TIA patients -Mathias Endres, Germany​

Plenary Session - Stroke for the "dummies" 2

Chairs: Heinrich Mattle, Switzerland
        Dafin Muresanu, Romania

• Asymptomatic carotid stenosis - Natan Bornstein, Israel​
• How to manage a patient with TIA in the first three months - Francisco Purroy, Spain​
• Up-date on secondary stroke prevention - ​David Tanne, Israel​
• Acute phase management : what Is best not to do (re BP, anticoagulation, etc..) ​- Michael Brainin, Austria